{"transactions":[{"id":1009208,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:54.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4588,"price":0.434,"value":1991.192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,762 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":146568,"source":{"system":"sec-edgar","filing":"0001477932-25-007902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007902/form4.xml","form_type":"4"}},{"id":1063243,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:00.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":19524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 19,524 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 9,762 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":151156,"source":{"system":"sec-edgar","filing":"0001477932-25-006099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006099/form4.xml","form_type":"4"}},{"id":1075695,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:41.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6142,"price":0.64,"value":3930.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,069 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":131632,"source":{"system":"sec-edgar","filing":"0001477932-25-005473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005473/form4.xml","form_type":"4"}},{"id":1093767,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:14.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4401,"price":0.7679,"value":3379.5279,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,365 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":137774,"source":{"system":"sec-edgar","filing":"0001477932-25-004912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004912/form4.xml","form_type":"4"}},{"id":1126733,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:05:46.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4598,"price":0.503,"value":2312.794,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,784 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":142175,"source":{"system":"sec-edgar","filing":"0001477932-25-004368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004368/form4.xml","form_type":"4"}},{"id":1126732,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:05:46.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":13069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 13,069 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,357 units, 4,356 units, and 4,356 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":146773,"source":{"system":"sec-edgar","filing":"0001477932-25-004368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004368/form4.xml","form_type":"4"}},{"id":1160389,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-05T20:06:03.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3913,"price":0.4875,"value":1907.5875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 8,326 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":133704,"source":{"system":"sec-edgar","filing":"0001477932-25-003319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225003319/form4.xml","form_type":"4"}},{"id":1233965,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:02:02.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":10142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2025, the reporting person was awarded 10,142 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,381 units, 3,381 units, and 3,380 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":137617,"source":{"system":"sec-edgar","filing":"0001477932-25-001460","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225001460/form4.xml","form_type":"4"}},{"id":1346413,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:01:10.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":9365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 1, 2024, the reporting person was awarded 9,365 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,122 units, 3,122 units, and 3,121 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":127475,"source":{"system":"sec-edgar","filing":"0001477932-24-007800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007800/form4.xml","form_type":"4"}},{"id":1417088,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-04T20:05:46.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":9784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 1, 2024, the reporting person was awarded 9,784 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,262 units, 3,261 units, and 3,261 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":118110,"source":{"system":"sec-edgar","filing":"0001477932-24-005501","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005501/form4.xml","form_type":"4"}},{"id":1494259,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:06:38.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":8326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2024, the reporting person was awarded 8,326 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,776 units, 2,775 units, and 2,775 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":108326,"source":{"system":"sec-edgar","filing":"0001477932-24-003489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003489/form4.xml","form_type":"4"}},{"id":1502960,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":73666,"kind":"person","name":"Retter Andrew","position":1,"cik":"0002015252","reported_name":"Retter Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-24T20:05:34.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with his employment as Chief Medical Officer of Volition Diagnostics UK Limited, Dr. Retter received restricted stock units (\"RSUs\") subject to a 3-year vesting schedule, vesting as to 33,334 units, 33,333 units, and 33,333 units on each of May 23, 2025, May 23, 2026 and May 23, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001477932-24-003295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003295/form4.xml","form_type":"4"}}]}